Dr. Jenny Zhou, MD

Dr. Zhou practices at Los Angeles Cancer Network in Vannuys, California.

Dr. Zhou's NPI, 1679992770, was assigned on April 16, 2014. Dr. Zhou graduated from Lewis Katz School of Medicine in 2014. Dr. Zhou holds California license A140567.

Dr. Zhou's primary practice is Los Angeles Cancer Network, at 6850 N Sepulveda Blvd, Vannuys, CA 91405 in Los Angeles County. The practice phone is (213) 977-1214.

Dr. Zhou's primary practice is Los Angeles Cancer Network in Vannuys, California. Dr. Zhou is also affiliated with USC Arcadia Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Zhou to 3 more hospitals, 1 group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhou practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Zhou's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zhou is board certified in hematology by the American Board of Internal Medicine. Dr. Zhou is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma and prostate cancer among the conditions Dr. Zhou treats.

CMS data shows 307 Medicare services from Dr. Zhou across 7 procedure codes in 2024, for 135 Medicare patients. Medicare paid $22,292 for them.

CMS counts 135 Medicare patients who saw Dr. Zhou in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhou's median patient age at 70, with 58% women.

In 2024, Dr. Zhou wrote 95 Medicare Part D claims for 25 patients. 59% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $12,311 in total drug cost. In 2023, CMS named 55 claims across 4 drugs.

Dr. Zhou accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Zhou, published from 2017 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Hemophilia A, Hemarthrosis and Vascular Remodeling. Dr. Zhou has published most often in Clin Appl Thromb Hemost. Dr. Zhou's most frequent co-authors are Annette Von Drygalski, MD, Eric Y. Chang, MD and Srila Gopal, MD.

CMS Open Payments shows 44 general payments to Dr. Zhou from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,317. It also lists 1 research payment totaling $200 in 2025.

Dr. Zhou graduated from Lewis Katz School of Medicine in 2014.

Dr. Zhou is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.